Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Accelerated Access Review

- PMLiVE

Takeda’s HAE drug Takhzyro backed by NICE

New treatment option for rare, hereditary disease

- PMLiVE

When it’s OK to not be OK: Bedrock breaks down mental health stigma

As part of Bedrock’s Wellbeing Programme, Bedrock paired up with Simpila to talk about mental health challenges and open up about the pressures we all face, both in and out...

Bedrock Healthcare Communications

- PMLiVE

Envision Pharma Group relocates to support expansion

Office moves in the US prompted by significant growth

Biomarin

NICE approves BioMarin’s Brineura after initial setback

First treatment for rare disease

- PMLiVE

Lucid Group increases footprint in UK, Asia Pacific and Middle East with the acquisition of HealthCare21

Lucid Group is delighted to announce its latest acquisition, welcoming colleagues from Healthcare consultancy HealthCare21 into its magic kingdom.Over the last twelve years, Lucid Group has become well known and...

Lucid Group Communications Limited

- PMLiVE

Lucid Group Lucky Lunches prove a spellbinding hit this summer

Lucid Group Lucky Lunches have been running throughout the summer months, giving our teams the chance to network and connect outside of the office - as well as enjoying a...

Lucid Group Communications Limited

- PMLiVE

Lucid’s Summer Fridays Shone

Lucid Group has been enjoying long weekends throughout the summer thanks to Summer Fridays, a concept introduced in line with Lucid’s agile working policy.Employees have been encouraged to spread their...

Lucid Group Communications Limited

- PMLiVE

Bedrock creates waves

The Bedrock team were awash with ideas at their summer watersports and BBQ event. All were Bravely Bedrock in a host of activities – including wakeboarding, paddle boarding and taming...

Bedrock Healthcare Communications

Celebrating Ten Magical Years with Clare Reynolds

Lucid loves to recognise and celebrate the magic people create for their clients, teams and patients. This month it was time to recognise the outstanding contribution that Clare Reynolds has...

Lucid Group Communications Limited

- PMLiVE

NICE backs NHS use of Novartis’ gene therapy Luxturna

First and only therapy for rare, inherited form of blindness

Building the Lucid Group Brand

Dennis O'Brien, Lucid Group CEO, discusses how they will grow the organisation and develop the Lucid Group brand over the next twelve years.

Lucid Group Communications Limited

armadillo in chains

Should there be a punishment?

I mean for people who use the word innovation willy-nilly.Is it just us here at P&P, or has the word lost its meaning? Dictionaries define it as a new idea...

Page & Page and Partners

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links